Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neurogene Inc
NGNECurrent price
34.52 USD
-4.33 USD (-11.14%)
Last closed
39.2 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 011 458 816 USD
Yield for 12 month
+162.27 %
1Y
3Y
5Y
10Y
15Y
NGNE
Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York. Address: 535 W 24th Street, New York, NY, United States, 10011
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
51.4 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+925 000 USD
Last Quarter
–
Current Year
-3 262 000 USD
Last Year
-3 196 000 USD
Current Quarter
+108 000 USD
Last Quarter
-825 000 USD
Key Figures NGNE
1 year
3 years
5 years
10 years
EBITDA
-65 467 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-32.36 %
PEG Ratio
–
Return On Equity TTM
-41.34 %
Wall Street Target Price
51.4 USD
Revenue TTM
925 000 USD
Book Value
11.93 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-3.66 USD
Diluted Eps TTM
-3.66 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NGNE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NGNE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:4
Payout Ratio
–
Last Split Date
19.12.2023
Dividend Date
–
Stock Valuation NGNE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
855.2998
Price Sales TTM
1093.469
Enterprise Value EBITDA
-8.016
Price Book MRQ
5.7175
Financials NGNE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NGNE
For 52 weeks
12.49 USD
74.49 USD
50 Day MA
46.09 USD
Shares Short Prior Month
1 896 815
200 Day MA
38.76 USD
Short Ratio
6.53
Shares Short
934 605
Short Percent
8.05 %
BeatStart